Myeloproliferative neoplasms:ten years after the discovery of JAK2 V617F gene mutation
10.3760/cma.j.issn.1009-9921.2015.07.001
- VernacularTitle:骨髓增殖性肿瘤研究进展:JAK2 V617F基因突变发现后10年
- Author:
Ding TIAN
- Publication Type:Journal Article
- Keywords:
Myeloproliferative neoplasms,MPN;
Myeloproliferative disorders,MPD;
JAK2 V617F gene mutation;
Interferon-alpha
- From:
Journal of Leukemia & Lymphoma
2015;24(7):385-387
- CountryChina
- Language:Chinese
-
Abstract:
This article focuses on the rapidly evolving understanding of the molecular pathogenetic mechanisms of the bcr-abl-negative myeloproliferative neoplasms (MPN) [myeloproliferative disorders (MPD)],such as polycythemia vera (PV),essential thrombocythemia (ET),and primary myelofibrosis (MF).The amplify therapies were reviewed and IFN-α is an effective agent for these MPN (MPD).Also,the article emphasize once again avoidance MPN and select MPD for such chinese patients.